Fran Robinson talks to a patient who has had asthma all her life, feels that annual asthma reviews are a waste of time (except when they are conducted by PCRS members). In this article she explains why and Ren Lawlor, Senior Lecturer, Advanced Nurse Practitioner, Department of Adult Nursing and Paramedic Science, University of Greenwich reflects on this patient’s experiences.
a PCRS pragmatic guide
PCRS welcome this further update of the long established, comprehensive and highly respected BTS/SIGN guideline for asthma. We are pleased that today BTS/SIGN have announced that future UK-wide guidance for the diagnosis and management of chronic asthma will be jointly produced by BTS, SIGN and NICE, something PCRS has campaigned for (Keeley & Baxter 2018).
The fractional exhaled nitric oxide (FeNO) test measures the level of NO in the exhaled breath and provides an indication of eosinophilic inflammation in the lungs. Alongside a detailed clinical history and other important tests to assess variability (peak flow, reversibility and challenge tests) it is used to support the diagnosis of asthma. PCRS has produced this consensus position on the use of FeNO in primary care to support the diagnosis of asthma.
We have guidelines on asthma from two different sources in the UK – BTS/SIGN and NICE. The British Asthma guideline from BTS/SIGN was first published in 2003 and is well established, respected and comprehensive. NICE decided to develop first a guideline on diagnosis and monitoring in asthma, and then a guideline on asthma management, and they finally came together in a single published guideline in November 2017.
Briefing document for National Respiratory Strategies – the NHS Long term plan and Lung Health Taskforce 5 year plan.
This is the most recent briefing paper on the latest update to the BTS/SIGN British Asthma Guideline.